General Announcement for PLC

30/03/2022

OTHERS Memorandum of Understanding between Pharmaniaga Manufacturing Berhad and Prime Medical Store L.L.C

PHARMANIAGA BERHAD

Type Announcement
Subject OTHERS
Description 
Memorandum of Understanding between Pharmaniaga Manufacturing Berhad and Prime Medical Store L.L.C

The Board of Directors of Pharmaniaga Berhad (“the Company”) wishes to announce that Pharmaniaga Manufacturing Berhad (“PMB”), a wholly-owned subsidiary of the Company has on 30 March 2022 entered into a Memorandum of Understanding (“MOU”) with Prime Medical Store L.L.C to establish a basis of co-operation and collaboration between the parties in relation to the commercialization of PMB’s product in UAE.

Please refer to the attachment for details of the announcement.

This announcement is dated 30 March 2022.


Please refer attachment below.


Announcement Info

Company Name PHARMANIAGA BERHAD
Stock Name PHARMA
Date Announced 30 Mar 2022
Category General Announcement for PLC
Reference Number GA1-28032022-00025


Related Announcements for PHARMA
Date Title
25/02/2022 OTHERS Memorandum of Understanding between Pharmaniaga Research Centre Sdn Bhd and Bio-Innova Co. Ltd
25/02/2022 OTHERS Memorandum of Understanding between Pharmaniaga Lifescience Sdn Bhd & Bionet Asia Co. Ltd.
11/01/2022 OTHERS UPDATE ON THE CONCESSION AGREEMENT DATED 16 MARCH 2011 BETWEEN THE GOVERNMENT OF MALAYSIA (REPRESENTED BY THE MINISTRY OF HEALTH OF MALAYSIA) AND PHARMANIAGA LOGISTICS SDN BHD (Announcement pursuant to Chapter 9 of Bursa Malaysia Securities Berhad's Main Market Listing Requirement)
30/12/2021 OTHERS UPDATE ON THE CONCESSION AGREEMENT DATED 16 MARCH 2011 BETWEEN THE GOVERNMENT OF MALAYSIA (REPRESENTED BY THE MINISTRY OF HEALTH OF MALAYSIA) AND PHARMANIAGA LOGISTICS SDN BHD (Announcement pursuant to Chapter 9 of Bursa Malaysia Securities Berhad's Main Market Listing Requirement)
01/11/2021 MEMORANDUM OF UNDERSTANDING Pharmaniaga Berhad ("Pharmaniaga" or "the Company") Memorandum of Understanding between Pharmaniaga Research Centre Sdn Bhd, a wholly-owned subsidiary of the Company and National Institutes of Biotechnology Malaysia.
12/08/2021 OTHERS Surat Setuju Terima for the Supply and Distribution of Covid-19 Vaccine Coronavac Suspension for Injection between Pharmaniaga Lifescience Sdn Bhd, a wholly-owned subsidiary of Pharmaniaga Berhad and Government of Malaysia.
07/07/2021 NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : BONUS ISSUES PHARMANIAGA BERHAD ("PHARMANIAGA" OR "COMPANY") BONUS ISSUE
06/07/2021 NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : BONUS ISSUES PHARMANIAGA BERHAD ("PHARMANIAGA" OR "COMPANY") BONUS ISSUE
19/05/2021 NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : BONUS ISSUES PHARMANIAGA BERHAD ("PHARMANIAGA" OR "COMPANY") PROPOSED BONUS ISSUE
10/05/2021 NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : BONUS ISSUES PHARMANIAGA BERHAD ("PHARMANIAGA" OR ''COMPANY'') PROPOSED BONUS ISSUE